???pagination.result.count???
???pagination.result.page???
1
Regulation of gene expression downstream of a novel Fgf/Erk pathway during Xenopus development. , Cowell LM., PLoS One. January 1, 2023; 18 (10): e0286040.
Targeted search for scaling genes reveals matrixmetalloproteinase 3 as a scaler of the dorsal- ventral pattern in Xenopus laevis embryos. , Orlov EE., Dev Cell. January 10, 2022; 57 (1): 95-111.e12.
Xenopus Pkdcc1 and Pkdcc2 Are Two New Tyrosine Kinases Involved in the Regulation of JNK Dependent Wnt/PCP Signaling Pathway. , Vitorino M., PLoS One. August 13, 2015; 10 (8): e0135504.
Expression pattern of zcchc24 during early Xenopus development. , Vitorino M., Int J Dev Biol. January 1, 2014; 58 (1): 45-50.
Retinol dehydrogenase 10 is a feedback regulator of retinoic acid signalling during axis formation and patterning of the central nervous system. , Strate I., Development. February 1, 2009; 136 (3): 461-72.
Cholesterol homeostasis in development: the role of Xenopus 7-dehydrocholesterol reductase ( Xdhcr7) in neural development. , Tadjuidje E ., Dev Dyn. August 1, 2006; 235 (8): 2095-110.
R-Spondin2 is a secreted activator of Wnt/beta-catenin signaling and is required for Xenopus myogenesis. , Kazanskaya O., Dev Cell. October 1, 2004; 7 (4): 525-34.
Flamingo, a cadherin-type receptor involved in the Drosophila planar polarity pathway, can block signaling via the canonical wnt pathway in Xenopus laevis. , Morgan R., Int J Dev Biol. May 1, 2003; 47 (4): 245-52.
The small GTPase Rap1 is an immediate downstream target for Hoxb4 transcriptional regulation. , Morsi El-Kadi AS., Mech Dev. May 1, 2002; 113 (2): 131-9.
Characterization of the Ets-type protein ER81 in Xenopus embryos. , Chen Y , Chen Y ., Mech Dev. January 1, 1999; 80 (1): 67-76.
Integrin alpha 5 during early development of Xenopus laevis. , Joos TO ., Mech Dev. April 1, 1995; 50 (2-3): 187-99.
Catenins in Xenopus embryogenesis and their relation to the cadherin-mediated cell-cell adhesion system. , Schneider S., Development. June 1, 1993; 118 (2): 629-40.